Portugal, April 1 -- Portugal based GILEAD SCIENCES has secured contract from Ipo Porto Fg, Epe for Adcm 0498/26 - Autotransdanti-Cd19 Cd3 Cells 04-2X10e8 Cell Disp Inj 68 Ml (Brexucabtagene)1068526. The value of the contract is worth 27208400 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....